Prenuvo
PrivateLast Round
Series B
Feb 13, 2025
Total Funding Raised
$191.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Prenuvo operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Series B round in February 2025.
Prenuvo is a healthcare technology company that provides whole-body magnetic resonance imaging scan technology for proactive health screening and early disease detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Precision Medicine, Subscription Commerce, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prenuvo Comparables
Compare Prenuvo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neko Health | 87% | |
| Function Health | 87% | |
| Craft Health | 79% |
For institutional investors. Book with your work email.
Prenuvo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2025 | ||||
| Series A | Oct 18, 2022 | ||||
| Debt | Nov 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prenuvo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forerunner Ventures | Series B |
| BDC Capital | Debt |
| Steel Perlot | Series A |
| Left Lane Capital | Series B |
| Felicis Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Launched flagship clinic in London, United Kingdom.
- Jul 18, 2026
A new clinic has launched in North Vancouver, BC.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- opens_new_locationNov 3, 2026
Prenuvo establishes a mobile clinic in New York to provide Canadians with proactive health access, as Canadians cross the border for scans.
- partners_withOct 26, 2026
Prenuvo and UT Dallas collaborate on whole-body MRI research involving 14,031 adults that links sleep efficiency, visceral fat and brain volume, released on Oct 23rd '26.
- expands_offices_toSep 16, 2026
Prenuvo expands into California after setting up its first clinic in Canada in 2018 and later extends its presence across the United States.
For institutional investors. Book with your work email.
Prenuvo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prenuvo's valuation, stock price, and market status.
Is Prenuvo a public or private company?
Prenuvo is a private company.
What is the current stock price of Prenuvo?
Prenuvo is a private company, so its shares have no public market price. Caplight tracks Prenuvo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prenuvo worth (valuation)?
Valuation information for Prenuvo is not publicly available.
Can I buy Prenuvo stock?
Prenuvo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prenuvo's last funding round?
Prenuvo's most recent funding round was Series B on February 13, 2025.
Who are the main investors in Prenuvo?
Key investors in Prenuvo include Forerunner Ventures, BDC Capital, Left Lane Capital, Felicis Ventures.
Will Prenuvo IPO soon?
No public IPO plans have been announced for Prenuvo.
How can I track Prenuvo secondary market activity?
Caplight tracks bids, offers, and trades in Prenuvo's shares on secondary markets.